LG190178
LG190178 is a non-steroidal vitamin D receptor (VDR) ligand that can induce the formation of heterodimer complexes between VDR and retinoid X receptor (RXR), stabilizing the agonistic conformation of the VDR ligand-binding domain and promoting its interaction with co-activators. LG190178 has functions in regulating calcium homeostasis, bone mineralization, as well as cell proliferation, differentiation, and apoptosis, making it useful for research in psoriasis, osteoporosis, and cancer[1].
Product Specifications
CAS Number
233268-81-0
UNSPSC
12352005
Target
Apoptosis; RAR/RXR; VD/VDR
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Cancer; Metabolic Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/lg190178.html
Smiles
OCC(O)COC1=CC=C(C(C2=CC=C(OCC(O)C(C)(C)C)C(C)=C2)(CC)CC)C=C1C
Molecular Formula
C28H42O5
Molecular Weight
458.63
References & Citations
[1]Perakyla, et al. Gene regulatory potential of nonsteroidal vitamin D receptor ligands. Molecular endocrinology 19.8 (2005) : 2060-2073.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
HDDC2 (HD Domain-containing Protein 2, Hepatitis C Virus NS5A-transactivated Protein 2, C6orf74, CGI-130, NS5ATP2, dJ167O5.2) (MaxLight 490)
HDDC2 (HD Domain-containing Protein 2, Hepatitis C Virus NS5A-transactivated Protein 2, C6orf74, CGI-130, NS5ATP2, dJ167O5.2) (MaxLight 490)
COX 1 (Cyclooxygenase-1, PGHS-1, Prostaglandin Endoperoxide Synthase-1, PHS 1, Ovarian Cancer Marker) (MaxLight 490) discontinued